CMP testing market seen growing to $28.57 billion by 2030
The comprehensive metabolic panel testing market is projected to rise from $19.94 billion in 2026 to $28.57 billion by 2030, according to a new forecast from The Business Research Company. Demand is being driven by chronic disease growth, broader diagnostic access and faster testing models, with North America leading today and Asia-Pacific expected to grow fastest.
Why it matters: - Comprehensive metabolic panel testing is a core blood test used to assess chemical balance, metabolic function and key organ health. - The market’s projected expansion signals rising demand for routine diagnostics, preventive screening and faster clinical decision-making. - Growth in CMP testing also reflects the widening burden of chronic disease, especially cardiovascular disease and diabetes.
What happened: - The Business Research Company released its Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report values the CMP testing market at $19.94 billion in 2026. - The market is forecast to reach $28.57 billion by 2030. - The report projects a 9.4% compound annual growth rate through 2030. - The release says the market has grown quickly in recent years because of chronic disease prevalence, wider diagnostic lab access, routine blood chemistry testing and more preventive screening.
The details: - A CMP test is a blood panel with 14 parameters. - The test helps evaluate nutritional status and monitor liver and kidney function. - The test also supports diagnosis, screening and ongoing tracking of health conditions. - The market grew from $18.34 billion in 2025 to $19.94 billion in 2026, a 8.7% CAGR in that historical period. - Future growth is tied to demand for fast diagnostics, decentralized testing, integrated laboratory automation, population health screening and more investment in diagnostic infrastructure. - Key trends include broader use of automated clinical chemistry analyzers, higher demand for routine metabolic screening, stronger integration of laboratory information systems, growth in point-of-care CMP testing and more focus on early disease detection. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report highlights updated graphics, market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards and market hotspot infographics. - A free sample of the report is available. - The full report is also available.
Between the lines: - The forecast suggests CMP testing is shifting from a routine lab service into a more automated and distributed diagnostic category. - Growth in point-of-care and decentralized testing points to pressure for quicker results outside traditional laboratory settings. - The report’s focus on population health screening suggests health systems are treating CMP testing as part of broader preventive care strategies. - The CDC reported in October 2024 that cardiovascular disease caused 919,032 deaths in 2023, or one in every three deaths, underscoring the diagnostic need behind CMP demand.
What's next: - The report expects more adoption of automated analyzers and laboratory information system integration as testing volumes rise. - Asia-Pacific’s growth outlook suggests expanding healthcare access and diagnostic capacity will remain key market drivers. - Greater investment in diagnostics may help support early detection and wider routine screening over the next several years.
The bottom line: - CMP testing is moving into a higher-growth phase as chronic disease screening, automation and faster diagnostics reshape the market.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
The Business Gazette Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.